BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37927019)

  • 1. [Characterization of Cell Subsets Associated With Prognosis of Osteosarcoma Based on Single-Cell Sequencing Data].
    Wang ST; Zhu HR; Xu SJ; Gui P; Chen MZ; Li ZX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Oct; 45(5):773-782. PubMed ID: 37927019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis.
    Lv Y; Wu L; Jian H; Zhang C; Lou Y; Kang Y; Hou M; Li Z; Li X; Sun B; Zhou H
    Front Immunol; 2022; 13():997765. PubMed ID: 36275664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell Differentiation Trajectory-Associated Molecular Classification of Osteosarcoma.
    Xu A; Qian C; Lin J; Yu W; Jin J; Liu B; Tao H
    Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteosarcoma-Associated Immune Genes as Potential Immunotherapy and Prognosis Biomarkers.
    Yang L; Long Y; Xiao S
    Biochem Genet; 2024 Apr; 62(2):798-813. PubMed ID: 37452172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of B cell marker genes based on single-cell sequencing to establish a prognostic model and identify immune infiltration in osteosarcoma.
    Zhang Z; Zhang J; Duan Y; Li X; Pan J; Wang G; Shen B
    Front Immunol; 2022; 13():1026701. PubMed ID: 36569871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and immunological significance of an M1 macrophage-related gene signature in osteosarcoma.
    Mao X; Song F; Jin J; Zou B; Dai P; Sun M; Xu W; Wang L; Kang Y
    Front Immunol; 2023; 14():1202725. PubMed ID: 37465666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reanalysis of single-cell data reveals macrophage subsets associated with the immunotherapy response and prognosis of patients with endometrial cancer.
    Wu Q; Jiang G; Sun Y; Li B
    Exp Cell Res; 2023 Sep; 430(2):113736. PubMed ID: 37541419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-cell RNA datasets and bulk RNA datasets analysis demonstrated
    Tu J; Wang D; Zheng X; Liu B
    Front Immunol; 2023; 14():911368. PubMed ID: 36814925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel molecular signature for predicting prognosis and immunotherapy response in osteosarcoma based on tumor-infiltrating cell marker genes.
    Tang H; Liu S; Luo X; Sun Y; Li X; Luo K; Liao S; Li F; Liang J; Zhan X; Wei Q; Liu Y; He M
    Front Immunol; 2023; 14():1150588. PubMed ID: 37090691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance and immune landscape of a novel ferroptosis-related prognosis signature in osteosarcoma.
    Yang L; Liu J; Liu S
    BMC Cancer; 2023 Mar; 23(1):229. PubMed ID: 36899330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infiltration of LPAR5
    He Y; Zhou H; Huang X; Qu Y; Wang Y; Pei W; Zhang R; Chen S; You H
    Front Immunol; 2022; 13():909932. PubMed ID: 36591220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of immunogenic cell death indicates prognosis and tumor microenvironment infiltration in osteosarcoma.
    Liu Z; Liu B; Feng C; Li C; Wang H; Zhang H; Liu P; Li Z; He S; Tu C
    Front Immunol; 2022; 13():1071636. PubMed ID: 36569869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-541 serves as a prognostic biomarker of osteosarcoma and its regulatory effect on tumor cell proliferation, migration and invasion by targeting TGIF2.
    Liu C; Yi X
    Diagn Pathol; 2020 Jul; 15(1):96. PubMed ID: 32709240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A tumor microenvironment-based prognostic index for osteosarcoma.
    Wu C; Gong S; Duan Y; Deng C; Kallendrusch S; Berninghausen L; Osterhoff G; Schopow N
    J Biomed Sci; 2023 Apr; 30(1):23. PubMed ID: 37055822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploration of Immune-Related Gene Expression in Osteosarcoma and Association With Outcomes.
    Liu W; Xie X; Qi Y; Wu J
    JAMA Netw Open; 2021 Aug; 4(8):e2119132. PubMed ID: 34342651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and validation of an oxidative-stress-related risk model for predicting the prognosis of osteosarcoma.
    Wang H; Li J; Li X
    Aging (Albany NY); 2023 Jun; 15(11):4820-4843. PubMed ID: 37285835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hexosamine biosynthesis pathway-related gene signature correlates with immune infiltration and predicts prognosis of patients with osteosarcoma.
    Su Z; Wang C; Pan R; Li H; Chen J; Tan J; Tian X; Lin T; Shen J
    Front Immunol; 2022; 13():1028263. PubMed ID: 36275679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of apoptosis-related signature and molecular subtype to improve prognosis prediction in osteosarcoma patients.
    Hong J; Li Q; Wang X; Li J; Ding W; Hu H; He L
    J Clin Lab Anal; 2022 Jul; 36(7):e24501. PubMed ID: 35576501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prognostic Model Established by the Differential Expression Genes Based on CD8
    Chen Y; Yan W; Wang H; Ou Z; Chen H; Huang Z; Yang J; Liu B; Ou F; Zhang H
    Mediators Inflamm; 2023; 2023():6563609. PubMed ID: 36816742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TYROBP, TLR4 and ITGAM regulated macrophages polarization and immune checkpoints expression in osteosarcoma.
    Liang T; Chen J; Xu G; Zhang Z; Xue J; Zeng H; Jiang J; Chen T; Qin Z; Li H; Ye Z; Nie Y; Liu C; Zhan X
    Sci Rep; 2021 Sep; 11(1):19315. PubMed ID: 34588497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.